188 related articles for article (PubMed ID: 9157480)
41. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
42. Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG).
Eich HT; Müller RP; Engenhart-Cabillic R; Lukas P; Schmidberger H; Staar S; Willich N;
Strahlenther Onkol; 2008 Aug; 184(8):406-10. PubMed ID: 18956517
[TBL] [Abstract][Full Text] [Related]
43. Non-Hodgkin's lymphomas (NHL).
Gustafsson A
Acta Oncol; 1996; 35 Suppl 7():102-16. PubMed ID: 9154102
[TBL] [Abstract][Full Text] [Related]
44. Primary testicular lymphoma.
Zouhair A; Herrmann E; Ugurluer G; Gaye PM; Mirimanoff RO; Ozsahin M
Swiss Med Wkly; 2010; 140():w13076. PubMed ID: 20872294
[TBL] [Abstract][Full Text] [Related]
45. [Do we have to treat non-Hodgkin's lymphomas the same as Hodgkin's disease?].
Paunier JP
Schweiz Med Wochenschr; 1975 Oct; 105(40):1278-81. PubMed ID: 1215906
[TBL] [Abstract][Full Text] [Related]
46. The impact of pelvic recurrence and elective pelvic irradiation on survival and treatment morbidity in early-stage Hodgkin's disease.
Mendenhall NP; Taylor BW; Marcus RB; Million RR
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1157-65. PubMed ID: 1938513
[TBL] [Abstract][Full Text] [Related]
47. [Prognostic factors of malignant lymphoma].
Masaki N; Ikeda H; Matayoshi Y; Murayama S; Fujita M; Kozuka T
Gan No Rinsho; 1989 Oct; 35(13):1591-5. PubMed ID: 2685396
[TBL] [Abstract][Full Text] [Related]
48. Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma.
Yahalom J
J Clin Oncol; 2006 Feb; 24(4):544-8. PubMed ID: 16446326
[No Abstract] [Full Text] [Related]
49. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.
Tondini C; Zanini M; Lombardi F; Bengala C; Rocca A; Giardini R; Buzzoni R; Valagussa P; Bonadonna G
J Clin Oncol; 1993 Apr; 11(4):720-5. PubMed ID: 8478665
[TBL] [Abstract][Full Text] [Related]
50. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy.
Link MP; Donaldson SS; Berard CW; Shuster JJ; Murphy SB
N Engl J Med; 1990 Apr; 322(17):1169-74. PubMed ID: 2183052
[TBL] [Abstract][Full Text] [Related]
51. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
[TBL] [Abstract][Full Text] [Related]
52. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
[TBL] [Abstract][Full Text] [Related]
53. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
Kamath SS; Marcus RB; Lynch JW; Mendenhall NP
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):563-8. PubMed ID: 10348285
[TBL] [Abstract][Full Text] [Related]
54. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
[TBL] [Abstract][Full Text] [Related]
55. Suprahyoid Hodgkin's disease stage IA.
Bessell EM; MacLennan KA; Toghill PJ; Ellis IO; Fletcher J; Dowling FD
Radiother Oncol; 1991 Nov; 22(3):190-4. PubMed ID: 1771260
[TBL] [Abstract][Full Text] [Related]
56. Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.
Eich HT; Müller RP
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():16-8. PubMed ID: 18167000
[No Abstract] [Full Text] [Related]
57. Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
Bergeron C; Le Moine P; Le Prise-Fleury E; Jouan H; Tass P; Darcel F; Chatel M; Edan C; Patte C; Faivre J
Med Pediatr Oncol; 1993; 21(4):307-10. PubMed ID: 8469228
[TBL] [Abstract][Full Text] [Related]
58. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Wang WH; Li YX; Song YW; Jin J; Liu YP; Wang SL; Zhou LQ; Liu XF; Yu ZH; Han JZ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):218-21. PubMed ID: 16875611
[TBL] [Abstract][Full Text] [Related]
59. The basis for segmental sequential irradiation in Hodgkin's disease: extended vs. local fields in the radiocurability of the SJL-J mouse Hodgkin's-like reticulum cell sarcoma.
Rubin P; Haluska G
Am J Roentgenol Radium Ther Nucl Med; 1969 Apr; 105(4):806-13. PubMed ID: 4896081
[No Abstract] [Full Text] [Related]
60. [Modern pharmacotherapy of Hodgkin disease].
Josting A; Behringer K; Engert A; Diehl V
Internist (Berl); 2004 Jan; 45(1):93-101. PubMed ID: 14735247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
